NP-001 vaccine (UbiVac)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameNP-001 vaccine (UbiVac)

Drug Alias NameHPV E6 and E7 protein conjugated AL2O3 nanoparticle vaccine (UbiVac)HPV E6 and E7 protein conjugated aluminium oxide nanoparticle vaccine (UbiVac)NP-HPV vaccine (UbiVac)

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsPapillomavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUbivac

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUbivac

Active IndicationsN/A

Inactive IndicationsPapillomavirus Infections

Other Information

ATC CodeN/A